← Back to Search

Behavioral Intervention

Online Program for Endometriosis Pain

N/A
Recruiting
Led By Caroline Pukall, PhD
Research Sponsored by Dr. Caroline Pukall
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after the end of the program
Awards & highlights
No Placebo-Only Group

Summary

This trial will test an online program called PelvicSense designed to help people with endometriosis manage their pain. Participants will follow the program remotely and continue their usual treatments. The study aims to see if this program can improve pain and other health outcomes.

Who is the study for?
This trial is for adults over 18 who speak English and have been diagnosed with endometriosis, experiencing pain for at least three months. Participants will continue their usual treatment while being involved in the study.
What is being tested?
The PelvicSense online program's effectiveness on reducing pain and improving sexual outcomes in individuals with endometriosis is being tested. The study spans over a period of six months including assessments before, after the 3-month program, and a follow-up.
What are the potential side effects?
Since PelvicSense is an educational intervention rather than a medication, it may not have typical drug side effects; however, participants might experience discomfort or emotional distress when addressing sensitive topics.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after the end of the program
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after the end of the program for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pain intensity
Secondary study objectives
Pain catastrophizing
Other study objectives
Pain self-efficacy
Sexual distress

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: 3 month PelvicSense(R) programExperimental Treatment1 Intervention
PelvicSense® is a home-based physiotherapy program integrating multiple techniques, including relaxation, breathing, stretching, strengthening and at-home manual therapy. This program also educates participants about the anatomy and physiology of the pelvis and teaches strategies to strengthen the mind-muscle connection to the pelvis.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for endometriosis include hormonal therapies such as estrogen-progestin contraceptives, GnRH agonists and antagonists, and progestins like dienogest. These treatments work by reducing estrogen levels, which in turn decreases the growth and activity of endometrial tissue, thereby alleviating pain and other symptoms. Behavioral interventions, like the PelvicSense 3-month online program, aim to manage pain through psychological and physical therapy techniques, addressing the chronic pain and improving quality of life. This matters for endometriosis patients as it provides a multifaceted approach to pain management, combining medical and behavioral strategies to enhance overall outcomes.
State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials.Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.Pain and endometriosis: Etiology, impact, and therapeutics.

Find a Location

Who is running the clinical trial?

Dr. Caroline PukallLead Sponsor
2 Previous Clinical Trials
75 Total Patients Enrolled
Queen's UniversityLead Sponsor
375 Previous Clinical Trials
124,942 Total Patients Enrolled
Caroline Pukall, PhDPrincipal InvestigatorQueen's University
3 Previous Clinical Trials
95 Total Patients Enrolled

Media Library

PelvicSense(R) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05909579 — N/A
Endometriosis Research Study Groups: 3 month PelvicSense(R) program
Endometriosis Clinical Trial 2023: PelvicSense(R) Highlights & Side Effects. Trial Name: NCT05909579 — N/A
PelvicSense(R) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05909579 — N/A
~24 spots leftby Dec 2025